The company has finalized agreements with four key regional players to handle distribution and technical support: RChisto Soluções in Brazil, Ross Biotech Innovative Solutions in India, Dakewe Biotech in China, and Celtic Molecular Diagnostics in South Africa. These partnerships aim to streamline the supply chain for researchers navigating the difficulties of handling suspension and rare cells.
SmartBioSurface technology utilizes a proprietary nanostructured titanium coating to preserve cell morphology and integrity, addressing common failures in conventional sample preparation. By integrating these slides into existing workflows, laboratories can enhance their capabilities in liquid biopsy, immunology, and single-cell analysis. Holger Neecke, CEO of Tethis, noted that the move is a response to the specific hurdles researchers face when working with low-cellularity samples in rapidly expanding scientific sectors. This rollout ensures that local teams receive the necessary technical backing to utilize the technology for circulating tumor cell analysis and immune cell profiling.

Comments (0)
No comments yet. Be the first!